KCA

KVP Capital Advisors Portfolio holdings

AUM $96.8M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$96.8M
AUM Growth
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
25
New
Increased
Reduced
Closed

Top Buys

1 +$10.2M
2 +$7.99M
3 +$5.2M
4
AXSM icon
Axsome Therapeutics
AXSM
+$5.05M
5
WHWK
Whitehawk Therapeutics
WHWK
+$4.97M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TERN icon
1
Terns Pharmaceuticals
TERN
$4.45B
$17.8M 18.36%
+440,000
PRAX icon
2
Praxis Precision Medicines
PRAX
$9.44B
$12.6M 13.06%
+42,900
AXSM icon
3
Axsome Therapeutics
AXSM
$8.23B
$6.61M 6.83%
+36,200
WHWK
4
Whitehawk Therapeutics
WHWK
$153M
$5.24M 5.41%
+2,165,997
TRVI icon
5
Trevi Therapeutics
TRVI
$1.48B
$5.18M 5.35%
+414,000
INSM icon
6
Insmed
INSM
$32B
$4.96M 5.12%
+28,497
PTGX icon
7
Protagonist Therapeutics
PTGX
$5.53B
$4.63M 4.78%
+53,000
IRON icon
8
Disc Medicine
IRON
$2.56B
$4.63M 4.78%
+58,250
MBX
9
MBX Biosciences
MBX
$1.57B
$3.83M 3.96%
+121,524
SVRA icon
10
Savara
SVRA
$1.21B
$3.65M 3.77%
+605,280
TVTX icon
11
Travere Therapeutics
TVTX
$2.66B
$3.48M 3.59%
+91,000
EWTX icon
12
Edgewise Therapeutics
EWTX
$3.14B
$3.3M 3.41%
+133,000
JAZZ icon
13
Jazz Pharmaceuticals
JAZZ
$11.5B
$2.98M 3.07%
+17,500
SLNO icon
14
Soleno Therapeutics
SLNO
$2.05B
$2.76M 2.86%
+59,700
UTHR icon
15
United Therapeutics
UTHR
$21.7B
$2.31M 2.39%
+4,750
ACHV icon
16
Achieve Life Sciences
ACHV
$252M
$2.3M 2.37%
+462,355
RVMD icon
17
Revolution Medicines
RVMD
$19.7B
$2.19M 2.26%
+27,500
SRRK icon
18
Scholar Rock
SRRK
$4.57B
$1.98M 2.05%
+45,000
VERA icon
19
Vera Therapeutics
VERA
$3.01B
$1.66M 1.71%
+32,700
IMMX icon
20
Immix Biopharma
IMMX
$450M
$1.21M 1.24%
+230,423
NKTR icon
21
Nektar Therapeutics
NKTR
$1.84B
$1.14M 1.17%
+26,900
CABA icon
22
Cabaletta Bio
CABA
$335M
$1.11M 1.14%
+505,431
FULC icon
23
Fulcrum Therapeutics
FULC
$576M
$566K 0.58%
+50,000
CELC icon
24
Celcuity
CELC
$5.14B
$399K 0.41%
+4,000
VYNE icon
25
VYNE Therapeutics
VYNE
$19.8M
$290K 0.3%
+500,551